Stay updated on Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe Record History now shows a new revision entry v3.3.4 and removes v3.3.3, affecting only the version history metadata.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check30 days agoChange Detected- Revision: v3.3.3 added to the Record History; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page history now includes a new entry 'Revision: v3.3.2' and removes the previous 'Revision: v3.3.1' entry.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page history shows a minor revision entry (Revision: v3.3.1) that appears to be a system or UI update and does not alter core study information or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedThe notice about government funding delays and operating status was removed from the page header. It previously informed users about potential delays and where to find status updates.SummaryDifference0.7%

- Check80 days agoChange DetectedA new version entry (Version 12, 2024-12-10) was added to the Record History, noting updates to Study Status and Outcome Measures.SummaryDifference0.1%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.